$4.4 Billion is the total value of Redmile Group, LLC's 71 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 26.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $758,127,000 | -1.3% | 12,957,222 | 0.0% | 17.24% | +28.7% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $262,371,000 | +32.1% | 22,716,086 | +9.2% | 5.96% | +72.2% |
| New | SCIENCE 37 HOLDINGS INC | $247,009,000 | – | 19,808,234 | +100.0% | 5.62% | – | |
| ARGX | Sell | ARGENX SEsponsored adr | $182,674,000 | -17.2% | 521,643 | -28.6% | 4.15% | +7.9% |
| LIVN | Sell | LIVANOVA PLC | $179,859,000 | +3.7% | 2,057,178 | -6.1% | 4.09% | +35.1% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $164,295,000 | +0.1% | 2,587,730 | -7.4% | 3.74% | +30.5% |
| ADCT | Sell | ADC THERAPEUTICS SA | $150,511,000 | -26.4% | 7,451,029 | -1.0% | 3.42% | -4.1% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $150,283,000 | -12.5% | 1,885,850 | -4.5% | 3.42% | +14.0% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $127,372,000 | +23.1% | 1,820,898 | -8.1% | 2.90% | +60.4% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $122,801,000 | -36.8% | 5,082,805 | -32.1% | 2.79% | -17.6% |
| REPL | Sell | REPLIMUNE GROUP INC | $104,782,000 | -13.3% | 3,866,512 | -5.2% | 2.38% | +13.0% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $101,459,000 | -12.3% | 6,437,777 | -0.4% | 2.31% | +14.3% |
| IGMS | Sell | IGM BIOSCIENCES INC | $97,797,000 | -56.6% | 3,334,355 | -2.7% | 2.22% | -43.4% |
| NRIX | Sell | NURIX THERAPEUTICS INC | $85,642,000 | -7.6% | 2,958,284 | -4.4% | 1.95% | +20.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $83,678,000 | -49.1% | 2,165,586 | -28.8% | 1.90% | -33.6% |
| ABSCI CORPORATION | $65,855,000 | -29.5% | 8,031,094 | 0.0% | 1.50% | -8.1% | ||
| VERV | Sell | VERVE THERAPEUTICS INC | $62,994,000 | -28.3% | 1,708,536 | -8.6% | 1.43% | -6.5% |
| RGNX | Sell | REGENXBIO INC | $62,039,000 | -26.3% | 1,897,223 | -5.5% | 1.41% | -4.0% |
| IMGN | IMMUNOGEN INC | $61,277,000 | +30.9% | 8,258,345 | 0.0% | 1.39% | +70.5% | |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $60,806,000 | -27.8% | 2,447,926 | -4.0% | 1.38% | -5.9% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $58,830,000 | -12.7% | 2,789,496 | +8.6% | 1.34% | +13.8% |
| NVTA | Sell | INVITAE CORP | $58,109,000 | -61.6% | 3,805,403 | -28.4% | 1.32% | -49.9% |
| SGEN | Sell | SEAGEN INC | $57,486,000 | -42.4% | 371,839 | -36.7% | 1.31% | -24.9% |
| STOK | Sell | STOKE THERAPEUTICS INC | $53,898,000 | -11.1% | 2,246,668 | -5.7% | 1.22% | +15.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $52,468,000 | +11.2% | 104,488 | -13.4% | 1.19% | +45.0% |
| ICUI | Sell | ICU MED INC | $52,197,000 | +0.5% | 219,926 | -1.2% | 1.19% | +31.0% |
| ANTM | Sell | ANTHEM INC | $51,123,000 | +7.6% | 110,289 | -13.5% | 1.16% | +40.2% |
| Buy | SOMALOGIC INC | $48,222,000 | -2.0% | 4,142,770 | +4.3% | 1.10% | +27.7% | |
| STTK | SHATTUCK LABS INC | $47,825,000 | -58.2% | 5,619,914 | 0.0% | 1.09% | -45.6% | |
| AUGX | New | AUGMEDIX INC | $45,298,000 | – | 14,380,327 | +100.0% | 1.03% | – |
| GRTS | Buy | GRITSTONE BIO INC | $44,099,000 | +44.7% | 3,429,171 | +21.6% | 1.00% | +88.9% |
| PLRX | PLIANT THERAPEUTICS INC | $41,627,000 | -20.0% | 3,083,501 | 0.0% | 0.95% | +4.2% | |
| OSH | Sell | OAK STR HEALTH INC | $39,888,000 | -50.1% | 1,203,619 | -35.9% | 0.91% | -34.9% |
| PRTA | Sell | PROTHENA CORP PLC | $37,824,000 | -41.1% | 765,675 | -15.1% | 0.86% | -23.2% |
| ANNX | Sell | ANNEXON INC | $37,100,000 | -40.5% | 3,228,917 | -3.6% | 0.84% | -22.4% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $33,888,000 | -43.6% | 1,602,285 | -40.4% | 0.77% | -26.5% |
| New | ENTRADA THERAPEUTICS INC | $33,460,000 | – | 1,954,420 | +100.0% | 0.76% | – | |
| NUVB | Sell | NUVATION BIO INC | $31,204,000 | -30.9% | 3,671,009 | -19.2% | 0.71% | -9.9% |
| CNC | New | CENTENE CORP DEL | $29,758,000 | – | 361,139 | +100.0% | 0.68% | – |
| Sell | STEVANATO GROUP S P A | $26,272,000 | -12.6% | 1,170,225 | -1.4% | 0.60% | +13.9% | |
| GMAB | Sell | GENMAB A/Ssponsored ads | $26,174,000 | -46.5% | 661,621 | -40.9% | 0.60% | -30.3% |
| ISEE | New | IVERIC BIO INC | $25,080,000 | – | 1,500,000 | +100.0% | 0.57% | – |
| New | THE ONCOLOGY INSTITUTE INC | $24,375,000 | – | 2,500,000 | +100.0% | 0.55% | – | |
| IMTX | Sell | IMMATICS N.V | $23,731,000 | -6.0% | 1,765,692 | -9.1% | 0.54% | +22.7% |
| NVRO | Sell | NEVRO CORP | $21,898,000 | -65.3% | 270,116 | -50.2% | 0.50% | -54.8% |
| ALLK | Sell | ALLAKOS INC | $20,342,000 | -91.0% | 2,077,875 | -2.5% | 0.46% | -88.3% |
| BVS | Sell | BIOVENTUS INC | $19,201,000 | -9.0% | 1,325,139 | -11.1% | 0.44% | +18.8% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $16,826,000 | -33.6% | 3,490,835 | -0.5% | 0.38% | -13.3% |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $16,807,000 | -73.7% | 782,097 | -9.5% | 0.38% | -65.7% |
| ZGNX | Sell | ZOGENIX INC | $16,219,000 | +5.3% | 998,114 | -1.6% | 0.37% | +37.2% |
| LVTX | LAVA THERAPEUTICS NV | $15,489,000 | -7.1% | 2,816,196 | 0.0% | 0.35% | +21.0% | |
| MDVL | Sell | MEDAVAIL HOLDINGS INC | $15,505,000 | -54.7% | 11,075,105 | -5.5% | 0.35% | -41.0% |
| TKNO | ALPHA TEKNOVA INC | $14,848,000 | -17.7% | 725,000 | 0.0% | 0.34% | +7.3% | |
| ZYME | Sell | ZYMEWORKS INC | $14,331,000 | -44.1% | 874,397 | -0.9% | 0.33% | -27.1% |
| Sell | ADAGIO THERAPEUTICS INC | $13,946,000 | -89.8% | 1,920,960 | -40.8% | 0.32% | -86.7% | |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $12,493,000 | -88.9% | 98,064 | -88.6% | 0.28% | -85.5% |
| ALVR | Sell | ALLOVIR INC | $10,654,000 | -49.2% | 823,371 | -1.6% | 0.24% | -33.9% |
| STXS | Sell | STEREOTAXIS INC | $10,529,000 | +5.5% | 1,698,204 | -8.5% | 0.24% | +37.4% |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $10,461,000 | -35.7% | 2,088,089 | 0.0% | 0.24% | -16.2% | |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $10,321,000 | -80.4% | 582,805 | -76.7% | 0.24% | -74.4% |
| RCEL | Sell | AVITA MEDICAL INC | $8,055,000 | -66.2% | 672,411 | -50.1% | 0.18% | -56.0% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $6,495,000 | -95.3% | 664,817 | -83.5% | 0.15% | -93.8% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $6,273,000 | -80.7% | 1,346,058 | -64.7% | 0.14% | -74.7% |
| AYLA | AYALA PHARMACEUTICALS INC | $5,683,000 | -25.0% | 667,816 | 0.0% | 0.13% | -2.3% | |
| HOOK | Buy | HOOKIPA PHARMA INC | $5,557,000 | -48.8% | 2,385,136 | +29.3% | 0.13% | -33.3% |
| New | XERIS BIOPHARMA HOLDINGS INC | $3,066,000 | – | 1,046,587 | +100.0% | 0.07% | – | |
| CTSO | Sell | CYTOSORBENTS CORP | $3,005,000 | -64.6% | 717,244 | -31.3% | 0.07% | -54.1% |
| New | SONENDO INC | $2,869,000 | – | 498,131 | +100.0% | 0.06% | – | |
| CABA | CABALETTA BIO INC | $2,639,000 | -68.8% | 696,377 | 0.0% | 0.06% | -59.5% | |
| BCEL | Sell | ATRECA INC | $2,425,000 | -66.7% | 800,306 | -31.6% | 0.06% | -56.7% |
| EPZM | Sell | EPIZYME INC | $1,136,000 | -97.0% | 454,475 | -93.9% | 0.03% | -96.1% |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -40,674 | -100.0% | -0.00% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -38,912 | -100.0% | -0.00% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -54,758 | -100.0% | -0.00% | – |
| YMTX | Exit | YUMANITY THERAPEUTICS INC | $0 | – | -59,487 | -100.0% | -0.01% | – |
| XERS | Exit | XERIS PHARMACEUTICALS INC | $0 | – | -1,358,825 | -100.0% | -0.06% | – |
| APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -694,918 | -100.0% | -0.06% | – |
| ITMR | Exit | ITAMAR MED LTDsponsored ads | $0 | – | -264,600 | -100.0% | -0.14% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -787,346 | -100.0% | -0.20% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -600,432 | -100.0% | -0.21% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -1,222,408 | -100.0% | -0.31% | – |
| DYNS | Exit | DYNAMICS SPECIAL PURPOSE COR | $0 | – | -1,924,900 | -100.0% | -0.33% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -150,376 | -100.0% | -0.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.